"Clitoria ternatea (Butterfly Pea): A Comprehensive Review of Its Phytochemical Constituents, Pharmacological Properties, and Therapeutic Potential"

Clitoria ternatea L., commonly known as butterfly pea or aparajita, is a perennial climbing plant belonging to the family Fabaceae. It is cultivated as an ornamental plant and used in traditional medicine, food colouring, and forage systems. Different parts of the plant contain bioactive constituents, including anthocyanins, flavonoids, phenolic compounds, triterpenoids, and cyclotides. The blue flower pigments known as ternatins are polyacylated anthocyanins that have attracted interest because of their colour properties and antioxidant activity in experimental assays. Research has examined possible antioxidant, anti-inflammatory, glucose-regulating, neuropharmacological, antimicrobial, and cytoprotective activities. Proposed mechanisms include interactions with reactive species, modulation of inflammatory signalling, effects on post-meal glucose responses, and influence on pathways associated with memory. However, the strength of evidence differs among these activities, and much of the literature is based on chemical assays, cell cultures, or animal studies. A small human crossover study has investigated acute postprandial responses to a flower beverage, but this does not establish long-term therapeutic efficacy. This review summarizes the botanical identity, synonyms, morphological features, phytochemical constituents, proposed mechanisms, and reported pharmacological properties of C. ternatea. Further research is needed on standardized preparations, bioavailability, safety, and clinical effectiveness before definitive therapeutic claims can be made. [12]

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-06
DOI
https://doi.org/10.5281/zenodo.23999283
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

"Clitoria ternatea (Butterfly Pea): A Comprehensive Review of Its Phytochemical Constituents, Pharmacological Properties, and Therapeutic Potential"

Rupali Karale, Chaitanya Patil, Ashish Jamghare, Abhilasha Gambhirao et al.
4 links
Zenodo (CERN European Organization for Nuclear Research)
Medicinal Plant Research
article

"Clitoria ternatea (Butterfly Pea): A Comprehensive Review of Its Phytochemical Constituents, Pharmacological Properties, and Therapeutic Potential"

Rupali Karale, Chaitanya Patil, Ashish Jamghare, Abhilasha Gambhirao, Saniya Shelar, Raj Khateghare
article en

Abstract

Clitoria ternatea L., commonly known as butterfly pea or aparajita, is a perennial climbing plant belonging to the family Fabaceae. It is cultivated as an ornamental plant and used in traditional medicine, food colouring, and forage systems. Different parts of the plant contain bioactive constituents, including anthocyanins, flavonoids, phenolic compounds, triterpenoids, and cyclotides. The blue flower pigments known as ternatins are polyacylated anthocyanins that have attracted interest because of their colour properties and antioxidant activity in experimental assays. Research has examined possible antioxidant, anti-inflammatory, glucose-regulating, neuropharmacological, antimicrobial, and cytoprotective activities. Proposed mechanisms include interactions with reactive species, modulation of inflammatory signalling, effects on post-meal glucose responses, and influence on pathways associated with memory. However, the strength of evidence differs among these activities, and much of the literature is based on chemical assays, cell cultures, or animal studies. A small human crossover study has investigated acute postprandial responses to a flower beverage, but this does not establish long-term therapeutic efficacy. This review summarizes the botanical identity, synonyms, morphological features, phytochemical constituents, proposed mechanisms, and reported pharmacological properties of C. ternatea. Further research is needed on standardized preparations, bioavailability, safety, and clinical effectiveness before definitive therapeutic claims can be made. [12]

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 17%
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon